Rx Firms Feeling Re-Patriotic As Foreign Tax Bill Moves Through Congress
Executive Summary
Supporters of a tax change that would allow U.S. pharmaceutical companies to "repatriate" cash held by overseas affiliates appear confident that the proposal will be enacted into law this year
You may also be interested in...
Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out
Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year
Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out
Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year
Foreign Cash Repatriation Bill Can Pass If Tied To Jobs, Breaux Tells PhRMA
Legislation to allow pharmaceutical companies to transfer cash held by overseas affiliates to the U.S. has a chance to pass Congress this year - if the bill ensures that proceeds are devoted to the creation of new jobs, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla